In wake of unexpected patient deaths, MacroGenics closes down PhII cancer trial – Endpoints News
Business News
- In wake of unexpected patient deaths, MacroGenics closes down PhII cancer trial Endpoints News
- MacroGenics closes solid tumor clinical trial after 7 people die FierceBiotech
- Enoblituzumab Trial Ended Early Due to Safety Concerns in Head and Neck Squamous Cell Carcinoma OncLive
Source: Business News